Who is sponsoring ASSIST?

ASSIST is sponsored by Beijing Tiantan Hospital.

What condition does ASSIST study?

ASSIST studies Acute Ischemic Stroke.

What drugs are being tested in ASSIST?

Interventions: Aleeto, Placebo.

What is the status of ASSIST?

ASSIST is currently RECRUITING.

Last reviewed 2025-09-03 · How we verify

Aleeto in Acute ISchemic Stroke：A RandomISed Controlled Clinical Trial (ASSIST)

NCT06759753 PHASE2 RECRUITING

This study is a prospective, double-blind, 1:1:1 randomized controlled study aimed at evaluating the efficacy and safety of Aleeto treatment compared to placebo in improving the NIHSS score at 14 days in patients with moderate to severe acute ischemic stroke. It also aims to explore the neuroprotective effects of Aleeto in moderate to severe acute ischemic stroke and provide data support and evidence for future clinical trials and evidence-based medicine.

Details

Lead sponsor	Beijing Tiantan Hospital
Phase	PHASE2
Status	RECRUITING
Enrolment	192
Start date	Fri Mar 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Sat Jan 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Acute Ischemic Stroke

Interventions

Aleeto
Placebo

Countries

China